FDA issues ICH Q10 guidance and Q4B annexes
This article was originally published in The Gold Sheet
The International Conference on Harmonization Q10 quality systems guideline is now available in the form of FDA guidance, the agency said April 8. Also announced that day are three annexes to the ICH Q4B guideline for evaluation and recommendation of pharmacopoeial texts on microbiological examination of nonsterile products. They are for: microbial enumeration tests general chapter; tests for specified microorganisms general chapter; and acceptance criteria for pharmaceutical preparations and substances for pharmaceutical use general chapter
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.